JPRN-UMIN000039460已完成未知
Effect of switching from a combination therapy using DPP-4 inhibitor and insulin degludec to insulin degludec/liraglutide on blood glucose fluctuation in patients with type 2 diabetes - Effect of switching from a combination therapy using DPP-4 inhibitor and insulin degludec to insulin degludec/liraglutide on blood glucose fluctuation in patients with type 2 diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
Switching from DPP-4 inhibitor plus insulin degludec to IDegLira significantly improved MAGE from 74.9 (60.3, 97.7) mg/dL to 64.8 (52.0, 78.2) mg/dL (P < 0.05), as well as other indices of GV and 24-hour mean blood glucose concentration.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of anaphylaxis of insulin degludec or liraglutide 2) Unstable glycemic control 3) Severe hepatic dysfunction, renal dysfunction 4) Pregnancy 5) Diabetic ketosis, coma and precoma 6) Serious infection, pre-or post-surgery 7) Poor adherence to dietary therapy 8) Poor insulin secretion 9) Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments
研究者
相似试验
Unknown
不适用
A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 YearsType 2 Diabetes MellitusNCT01681550Nagaoka Red Cross Hospital500
已完成
不适用
The examination of effects of switching to GLP-1 analog liraglutide or adding on insulin glargine once daily for type 2 diabetes controlled insufficiently by DPP-4 inhibitors and other oral anti-diabetic agents combination (multicenter study).type 2 diabetes mellitusJPRN-UMIN000012224Toho University School of Medicine, Division of diabetes, metabolism and endocrinology60
已完成
不适用
In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safetyJPRN-UMIN000009908Diabetes Center,Tokyo Women's Medical University50
招募中
3 期
Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 AnalogueDiabetes Mellitus, Type 2 Treated With InsulinNCT05767255Hospital Universitario San Ignacio66
已完成
不适用
Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control in type2 diabetes with dyslipidemiaType 2 diabetes mellitusJPRN-UMIN000010397Yokohama City University Medical Center150